Capital Allocation

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

Komodor's new AI platform moves beyond reactive fixes, proactively preventing the structural inefficiencies that strand up to 30% of Kubernetes capacity.

Fold Holdings just sold $45M in Bitcoin to erase its debt. This bold pivot from treasury holding to strategic de-risking reveals a new playbook for survival.

With only 4% of US pets insured despite soaring vet costs, a new partnership signals a major shift. Is embedding insurance the key to this untapped market?

A new partnership between software specialist Cosylab and hardware innovator Heron aims to overcome the final hurdles in deploying a promising cancer therapy worldwide.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

A new routing model promises to solve the persistent liquidity and execution problems plaguing the $31B tokenized asset market. Is this the key?

Imagine's appointment of Mike Ritzenthaler isn't just a new hire; it's a calculated move to fuel growth. His track record signals a major financial overhaul.

A new report reveals a decisive shift in AI strategy, as soaring costs, data sovereignty, and complexity push production workloads from public to private clouds.

Broadcom’s VMware overhaul has left enterprises scrambling. A new, exclusive tier of 'Pinnacle' partners, like The Redesign Group, is emerging as the essential guide.

AMR Clinical's appointment of Bernard Dyson as CFO is more than a leadership change. It's a strategic move to navigate a complex industry and scale its patient-centric model.

The firm is betting that flexibility is the key to unlocking the next wave of SaaS revenue, challenging the rigid models that have defined embedded payments.

A new AssetMark study reveals many advisors' gains are just market lift. The real winners are building systems for hiring, referrals, and accountability.

A Cambridge startup is building a 'Common Crawl for the living world,' framing biological data as a strategic weapon in the US-China tech rivalry.

Wirex partners with Visa to test AI-driven payments, promising a future of automated commerce. But can they balance convenience with control and security?

BC.GAME's latest partnership isn't just news; it's a blueprint for a new digital economy where player activity and partner profits fuel a shared system.

Millions of Americans face a hidden tax threat within their retirement accounts. A new book by financial professionals details the risks and offers strategies.

As Vivos Therapeutics pitches its revolutionary sleep apnea solution to investors, it's not just selling a device; it's fighting for its financial life.

With a complex $72M financing deal, Park Systems is doubling down on its dominance in nanometrology. Is this the move that makes them indispensable to chip giants?

Beta Bionics faces a shareholder investigation after a slowdown in patient growth spooked investors. We decode the numbers and the broader risks of growth metrics.